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a b s t r a c t
Environmental contamination by pharmaceuticals and personal care products (PPCPs) is barely studied
in India despite being one of the largest global producers and consumers of pharmaceuticals. In this
study, 29 pharmaceuticals and six metabolites were determined in sewage treatment plants (STPs) in
Udupi (STPU: population served ~150,000) and Mangalore (STPM: population served ~450,000); the
measured mean concentrations ranged from 12 to 61,000 ng/L and 5.0 to 31,000 ng/L, respectively.
Atorvastatin (the most prescribed antihypercholesterolemic in India), mefenamic acid, and paraxanthine
were found for the first time in wastewater in India at the mean concentrations of 395 ng/L, 1100 ng/L,
and 13,000 ng/L, respectively. Select pharmaceutical metabolites (norverapamil and clopidogrel car-
boxylic acid) were found at concentrations of upto 7 times higher than their parent drugs in wastewater
influent and effluent. This is the first study in India to report mass loading and emission of PPCPs and
their select metabolites in STPs. The total mass load of all PPCPs analyzed in this study at STPU (4.97 g/d/
1000 inhabitants) was 3.6 times higher than calculated for STPM. Select recalcitrant PPCPs (carbamaz-
epine, diazepam, and clopidogrel) were found to have negative or no removal from STPU while additional
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treatment with upflow anaerobic sludge blanket reactor at STPM removed (up to 95%) these PPCPs from
STPM. Overall, 5.1 kg of caffeine, 4.1 kg of atenolol, 2.7 kg of ibuprofen, and 1.9 kg of triclocarban were
discharged annually from STPU. The PPCP contamination profile in the Indian STP was compared with a
similar study in the USA.
© 2016 Elsevier Ltd. All rights reserved.
1. Introduction
Pharmaceuticals and personal care products (PPCPs) enter the
environment as parent drugs, their metabolites, and transformed
products through industrial and/or domestic wastewater discharge
as well as the farm application of sewage sludge from sewage
treatment plants (STPs) (Halling-Sorensen et al., 1998). There is a
concern over the ecological threats posed by “down-the-drain”
chemicals including PPCPs in India; India is one of the top five
emerging pharmaceutical manufacturing countries due to the
recent relocation of global pharmaceutical industry from North
America and EU to Asian countries (Rehman et al., 2015). India is
one of the countries with largest drug consumption (Mathew and
Unnikrishnan, 2012), and ranked 11th in the global consumption
of over-the-counter drugs (Nagaraj et al., 2015).
In addition to the environmental discharge of significant
amount of residual PPCPs through industrial effluent (Gunnarsson
et al., 2009; Larsson et al., 2007), the treatment capacity of do-
mestic sewage in India is far below the quantity of sewage gener-
ated from 1.3 billion people (Subedi et al., 2015). In 2008, only 31%
of the total sewage produced (~38,254 million liters per day; MLD)
in 908 cities were treated (CPCB, 2010). The shortage in demand
and supply for the sewage treatment, inadequate maintenance of
STPs, and sewage overflow every year for ~3e4 months of
monsoon, consequently, can outweigh the estimated environ-
mental emission of PPCPs. The majority of centralized wastewater
treatment systems in developing countries consist of low-cost
stabilization tank and septic ponds, while advanced secondary/
tertiary treatments are common in developed countries (Kivaisi,
2001).
Over the past decade, research determining sources and overall
fates of PPCPs through STPs, and their distribution in multiple
environmental matrices including biota (Subedi et al., 2012),
wastewater (Metcalfe et al., 2010; Radjenovic et al., 2009), surface
water (Kolpin et al., 2002), drinking water (Benotti et al., 2009), and
sludge (Subedi et al., 2013) were studied in developed countries.
However, the frequency and concentration of PPCPs can vary
depending on the consumption pattern of drugs and the effec-
tiveness of wastewater treatment strategies (Kolpin et al., 2002).
The fates of PPCPs in STPs in India are poorly reported (Anumol
et al., 2016; Subedi et al., 2015). Moreover, the reported PPCPs
fate studies focused only on parent drugs (Anumol et al., 2016;
Prabhasankar et al., 2016; Singh et al., 2014). Environmental fate
studies are particularly important because 30e90% of the admin-
istered dose of drugs is typically excreted through urine or feces
(Halling-Sorensen et al., 1998), and metabolites of pharmaceuticals
can be as much pharmacologically active as their parent drugs
(Schwartz et al., 1985). A pilot study reported recently by our
research group was the first to estimate mass loadings, removal
efficiency, and environmental emission of wide-range of PPCPs and
their select metabolites including illicit drugs and artificial sweet-
ener in India (Subedi et al., 2015). We found ng/L to mg/L levels of
PPCP residues including some of the highest reported concentra-
tions in wastewater and sludge from Indian STPs.
PPCPs are capable of exerting toxic effects at relatively low
concentrations through specific modes of action, and can affect
non-target organisms at different trophic levels (Rehman et al.,
2015). Antipsychotics, antidepressants, and antibacterials are the
three most toxic classes of pharmaceuticals in the environment
(Fent et al., 2006; Asimakopoulos and Kannan, 2016). For instance,
at environmentally relevant concentrations, carbamazepine altered
the ultrastructural cellular reactions in liver, kidney and gills of
Oncorhynchus mykiss (rainbow trout) and Cyprinus carpio (common
carp) (Triebskorn et al., 2007); diazepam inhibited polyp regener-
ation of Hydra vulgaris (Pascoe et al., 2003), and metoprolol and
verapamil significantly changed the heartbeat of Daphnia magna
(Villegas-Navarro et al., 2003). Therefore, studies on the environ-
mental occurrence of fate of PPCPs are important. A detailed dis-
cussion on the toxicity of pharmaceutical residues in various test
organisms has been compiled by Halling-Sorensen et al. (1998).
In this study, occurrence and removal of 29 PPCPs and nine
metabolites including antischizophrenic, sedative-hypnotic-
anxiolytic, antidepressant, antihypertension, antimicrobial, anti-
biotic, analgesic, antihistamine, antiplatelet, anti-
hypercholesterolemic, UV-filter, and stimulant were determined in
two STPs located at Udupi andMangalore in southern India. Profiles
of occurrence of PPCPs in wastewater influent in India were also
compared with that in wastewater influents in the USA. This is the
first study to determine mass loading of a wide-range of PPCPs in
STPs from a week-long sampling event, removal efficiency, and
environmental emission of these chemicals from Indian STPs.
2. Material and methods
2.1. Reagents and chemicals
Standard stock solutions (100 or 1000 mg/mL) of individual
pharmaceuticals, metabolites, and their corresponding
isotopically-labeled standards were purchased from commercial
vendors, as described elsewhere (Subedi et al., 2015; Subedi and
Kannan, 2015). Purity of all of the standards were 95%. Formic
acid (98.2%) was from Sigma-Aldrich (St. Louis, MO, USA). Ultrapure
Deionizedwater was preparedwith the Barnstead ultrapure system
(Barnstead International, Dubuque, IA, USA). All standard stock
solutions were stored at 20 C.
2.2. Sample collection and preparation
Wastewater samples including raw wastewater (influent),
treated wastewater (effluent), and sludge were collected over a
seven-day period, from Sunday, May 19, 2013 to Saturday, May 25,
2013, consecutively from two STPs located in Udupi (STPU) and
Mangalore (STPM) in the State of Karnataka, southern India. The
wastewater influents were collected after the initial treatment that
included screening of large-sized debris followed by grit removal.
The wastewater effluents were collected at an outlet after the
treatment processes prior to discharge into the Arabian Sea. STPU
involves a conventional aerobic biological treatment with activated
sludge followed by final clarification and chlorine disinfection.
STPM involves upflow anaerobic sludge blanket reactor (UASBR),
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secondary aerobic biological treatment with activated sludge, final
clarification, and chlorine disinfection (Fig. S1). UASBR is expected
to remove >85% of organic materials (measured as chemical oxygen
demand) due to the simultaneous anaerobic bio-degradation and
sedimentation process. The removal of PPCPs from STPU was due to
the aerobic bio-degradation while the removal of PPCPs from STPM
was due to combined anaerobic and aerobic bio-degradation (in-
side UASBR). The two plants STPU (population served ~150,000) and
STPM (population served ~450,000) has an installed treatment ca-
pacity of 14.2 MLD (current flow rate of 7.5 MLD) and 81.7 MLD
(current flow rate of 12 MLD), respectively. Both plants received
wastewater predominantly (>75%) from household waste.
Sludge samples were collected for seven days in both STPs
within a sampling week from final clarifier tank at STPU and from
sludge pit (after UASBR) at STPM. The total sludge production (TSP)
at final clarification tank of STPU was 400 kg/d whereas TSP at
sludge pit in STPM was 133 kg/d. All samples were collected in pre-
cleaned polypropylene bottles rinsed with site wastewater prior to
sample collection, shipped frozen within 6 days to the Wadsworth
Center, Albany, USA where it was stored at 20 C until extraction
and further analysis.
Wastewater samples were analyzed by following the methods
described elsewhere with some modifications (Subedi et al., 2015;
Subedi and Kannan, 2015). Briefly, wastewater samples were
thawed at room temperature, 100 mL was spiked with a mixture of
isotopically labeled internal standards of PPCPs (50 ng), mixed well,
and allowed to equilibrate for ~30 min at room temperature. The
aqueous samples were extracted by passage through Oasis® HLB
6 cm3 (200 mg; Waters, Milford, MA) solid phase extraction (SPE)
cartridges. Prior to use, the cartridges were conditioned with 5 mL
of methanol and 5 mL of milli-Q water, and wastewater samples
were loaded at ~1 mL/min. Then, cartridges were allowed to dry for
~30 min under vacuum and then eluted with 6 mL of methanol
followed by 4 mL of a mixture of acetone, methanol, and ethyl
acetate (2:2:1 v/v/v). Cartridges were also eluted with 4 mL of
methanol containing 5% ammonia. The eluents were combined and
concentrated to ~100 mL under a gentle stream of nitrogen at 35 C
using a TurboVap® Evaporator (Zymark, Inc., Hopkinton, MA). The
final volume of the extract was adjusted to 1 mL with methanol in
an amber glass vial, and 10 mL of the extract was injected into HPLC-
MS/MS.
Sludge samples were analyzed by following the method
described elsewhere with some modifications (Subedi et al., 2013,
2014). Briefly, ~0.1 g of freeze-dried sludge was spiked with a
mixture of isotopically labeled internal standards and allowed to
equilibrate for ~30 min at room temperature. Spiked sludge sam-
ples were vortex-mixed for 1 min and extracted with 6 mL of
methanol:water mixture (5:3 v/v) using an ultrasonic bath (Bran-
son® Ultrasonics 3510R-DTH; Danbury, CT) for 30 min. Extracts
were centrifuged at 4000 rpm for 5 min (Eppendorf Centrifuge
5804, Hamburg, Germany), the supernatant was collected in a
polypropylene tube, and the extraction was repeated with 6 mL of
methanol. The extracts were combined and concentrated to ~1 mL
under a gentle stream of nitrogen. The concentrated extract was
diluted with milli-Q water to ~10 mL and purified by passage
through Oasis® HLB (6 cm3, 200 mg) cartridges, as described above
for wastewater samples. The final volume of the extract was
adjusted to 1 mL with methanol in an amber glass vial, and 10 mL of
the extract was injected into HPLC-MS/MS for analysis.
2.3. Instrumental analysis
PPCPs were analyzed using an API 2000 electrospray triple
quadrupole mass spectrometer (ESI-MS/MS; Applied Biosystems,
Foster City, CA), interfaced with an Agilent 1100 Series HPLC system
(Agilent Technologies, Santa Clara, CA). The autosampler was
maintained at 4 C. The analytes were separated using an Ultra
Biphenyl column (100 mm  2.1 mm, 5 mm) (Restek® Corporation,
Bellefonte, PA). Methanol and water (0.1% formic acid) as well as
methanol and 0.5 mM ammonia (aq) were used as mobile phases; a
description of the mobile phase gradient flow is presented in
Table S1. Target analytes were determined by multiple-reaction
monitoring (MRM) in positive mode of ionization while triclo-
carban, ibuprofen, and sulfamethoxazole were monitored in
negative ionization mode. Detailed information on the MRM tran-
sitions, analyte peak identification, and quantification is provided
in Table S2 (Subedi et al., 2014). Briefly, analyte peak identification
was based on the retention time (±0.05 min) and the ratio of
qualitative to quantitative transition-ion responses (±20%). The
quantitation of pharmaceuticals was based on the isotope dilution
method; however, bupropion, acetaminophen, mefenamic acid,
clindamycin, lincomycin, miconazole, and tiabendazole were
quantified based on the response of the corresponding internal
standards. Metabolites were quantified using the internal stan-
dards of the corresponding parent compounds (due to the lack of
labeled standards available for the metabolites). The calibration
curves were prepared by plotting concentration-dependent
response factor of each target analyte (peak area of analyte
divided by peak area of internal standard) versus the response-
dependent concentration factor (concentration of analyte divided
by concentration of internal standard). The regression coefficients
(r2) for seven-to nine-point calibration standards calculated by
equal weighting quadratic regression were 0.99 for all target
analytes. The limits of quantitation (LOQs) were determined as a
minimum concentration of analytes in sample extracts that pro-
vided a signal to noise ratio 10. LOQs of the target pharmaceuti-
cals and their metabolites in wastewater and sludge samples
ranged 0.1e50 ng/L and 0.5e50 ng/g, respectively. Continuing
calibration verification standards were injected before and after
every batch of samples, which showed recoveries at 100 ± 22%. A
method blank was analyzed with every batch of samples. The
concentrations of target pharmaceuticals and their metabolites in
method blanks were below the corresponding LOQ. The concen-
trations of the target chemicals in sludge are reported on a dry-
weight basis unless stated otherwise.
One sample was selected randomly for matrix spike (MS) and
matrix spike duplicate (MSD) analyses with each batch of samples
analyzed. Target pharmaceuticals (50 ng) and their corresponding
internal standards (50 ng) were each spiked, and were passed
through the entire analytical procedure. The average relative re-
coveries of target pharmaceuticals from wastewater and sludge
ranged from 75 to 100%. The recoveries of all pharmaceuticals and
their metabolites in spiked wastewater and sludge samples were
reported elsewhere (Subedi et al., 2013, 2014, 2015; Subedi and
Kannan, 2015).
2.4. Calculations
The mass loadings of pharmaceuticals and their select metab-
olites in STPs, removal efficiency through the treatment processes,
and emission from STPs were calculated using the following
equations (Eqns (1)e(3)), as reported elsewhere (Subedi et al.,
2015; Subedi and Kannan, 2014, 2015).
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Removal Efficiency ð%Þ ¼ ½Ci  F   ½ðCe  FÞ þ ðCs  TSPÞ½Ci  F 
 100
(2)










where Ci is the mean concentration of analyte in wastewater
influent (ng/L), Ce is the mean concentration of analyte in waste-
water effluent (ng/L), F is the daily flow of wastewater influent (L/
d), mass load/1000 inhabitants is the mean amount of individual
pharmaceutical compound introduced into STP (mg/d/1000 in-
habitants), Cs is the mean concentration of analyte in sludge (ng/g
wet weight), TSP is the total sludge production (g/d wet weight),
population is the number of inhabitants served by the STP, and
emission/1000 inhabitants is the mean amount of individual
pharmaceutical compound discharged through wastewater
effluent and sludge (mg/d/1000 inhabitants).
The partition ratio for each PPCP at STPUwas calculated based on
the assumption that PPCPs are in equilibrium between sludge and
effluent after aerobic biological treatment. Thus, the calculated
partition ratio was used to calculate the concentration of PPCPs in
sludge after aerobic treatment in STPM, and used to calculate the
removal efficiency and environmental emission.
3. Results and discussion
3.1. PPCPs in influent
All 29 PPCPs including two antischizophrenics (quetiapine and
aripiprazole), three sedatives-hypnotics-anxiolytics (lorazepam,
alprazolam, and carbamazepine), three antidepressants (venlafax-
ine, bupropion, and sertraline), four antihypertensions (proprano-
lol, atenolol, diltiazem, and verapamil), one antimicrobial
(triclocarban), six antibiotics (trimethoprim, sulfamethoxazole,
clindamycin, lincomycin, miconazole, and tiabendazole), four an-
algesics (ibuprofen, acetaminophen, codeine, and mefenamic acid),
one antihistamine (diphenhydramine), one antiplatelet (clopidog-
rel), one antihypercholesterolemic (atorvastatin), one UV-filter
(oxybenzone), and one stimulant (caffeine) were found in waste-
water influents in the two STPs (Table 1). Six of the nine pharma-
ceutical metabolites analyzed were also found in wastewater
influent (Table 1). Metabolites of antischizophrenics (norquetiapine
and dehydro-aripiprazole) and an antidepressant (norsertraline)
were not detected in influents from both STPs. The concentrations
of most of the PPCPs in influents at STPU were higher than the
concentrations of PPCPs at STPM. Antibiotics (trimethoprim and
clindamycin) and antidepressants (venlafaxine and a metabolite of
verapamil) were found at concentrations 6 times higher in STPU
than in STPM influents. The sum of mean concentrations of total 29
pharmaceuticals and six metabolites entering STPU and STPM were
99,500 ng/L and 51,800 ng/L, respectively.
Aripiprazole is the most selling prescription drug in the USA in
2013 (http://www.drugs.com/stats), and aripiprazole and quetia-
pine are among the top six antischizophrenics prescribed in India.
The mean concentrations of quetiapine and aripiprazole in in-
fluents were similar at STPU (Table 1), despite the higher pre-
scription frequency and mean dose of quetiapine than aripiprazole
(Grover and Avasthi, 2010). Typically, psychotic patients in India are
prescribed with two or more psychoactives (Grover and Avasthi,
2010). Diazepam was measured at a mean concentration of
25 ng/L in 100% of influent samples from STPM. Similarly, carba-
mazepine is one of the most commonly prescribed and co-
prescribed antiepileptic drugs with antischizophrenics and anxio-
lytics in India (Haroon et al., 2012). The mean concentration of
carbamazepine in influent in both STPs (~500 ng/L) was similar as
reported in wastewater from other parts of India (Anumol et al.,
2016; Subedi and Kannan, 2015) and Korea (Choi et al., 2008),
while but two times lower than in Canada (Lajeunesse et al., 2012).
Venlafaxine and bupropion were found in 100% of influent
samples from STPU at mean concentrations of 38 ng/L and 19 ng/L,
respectively.
Hypertension is a significant contributor of cardiovascular dis-
ease which is estimated to increase by 111% from 1990 (2.3 million
deaths in India) to 2020 in India (Gupta, 2004). All anti-
hypertensions (atenolol, propranolol, diltiazem, and verapamil)
were detected in 100% influent samples in both STPs. Atenolol is the
most prescribed antihypertensive (19.4%) in India (Rachana et al.,
2014). The mean concentration of atenolol in influent was 33e91
times higher than other antidepressants.
The mean concentration of triclocarban (an antimicrobial) was
3.3e138 times higher than the concentrations found for antibiotics
(Table 1). Antibiotics and antimicrobials constitute 6% of all human
prescription medicines and >70% of all veterinary medicines
(Thiele-Bruhn, 2003). The extensive agricultural and veterinary
facilities in Mangalore than in Udupi can explain two times higher
concentration of tiabendazole (a fungicide) at STPM than in STPU.
Analgesics are the largest group of over-the-counter drugs in India
(Nagaraj et al., 2015). Acetaminophen was detected as the next
highest compound after caffeine in 100% influent samples in both
STPs. The mean concentration of ibuprofen (1300 ng/L) was similar
to that reported previously in other five STPs in India (Subedi et al.,
2015) whilemefenamic acid (1100 ng/L) was found for the first time
in wastewater in India. Atorvastatin is the second most commonly
prescribed drug in the USA (http://www.rxlist.com) and the most
prescribed antihypercholesterolemic in India, but has not been
reported in wastewater prior to this study. The mean concentration
of atorvastatin was 395 ng/L detected for the first time in waste-
water from two STPs in India.
The higher concentration of metabolites of select drugs their
parent drugs emphasizes the importance of monitoring metabo-
lites in wastewater for the calculation of mass loads of drugs in
STPs. For example, the concentration of diltiazem in STPU was ~2
times lower than its parent drug while the mean concentration of a
metabolite of verapamil was 7.2 times higher than that of its parent
drug. Similarly, clopidogrel carboxylic acid, a metabolite of clopi-
dogrel (an antiplatelet), was found more frequently and at higher
concentrations than its parent drug.
3.2. Comparison of PPCP profiles in wastewater influent from India
and the USA
The mass loadings of select PPCPs in wastewater influents and
effluents from a STP in Udupi, India (STPU) and a STP in New York,
USA (Subedi and Kannan, 2015) serving similar size populations
were compared (Fig. 1). Wastewater samples from both STPs were
analyzed utilizing the same analytical method including the same
set of analytical instrumentations. The mean concentrations of
antipsychotics such as venlafaxine and bupropion were 8.8 and 7.7
times higher, respectively, in the USA than in India. However, the
mean concentrations of antipsychotics such as aripiprazole, al-
prazolam, and diazepam and an antihypertension (atenolol) were
5 times higher in India than in the USA. Moreover, the mean
concentrations of norverapamil (a metabolite of antihypertensive
verapamil) and oxazepam were 29 and 21 times higher in India
than in the USA. The ratio of the concentration of norverapamil to
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Table 1
Mean (n ¼ 7) concentrations of pharmaceuticals and their select metabolites in wastewater (ng/L) and sludge (ng/g dw) from two Indian sewage treatment plants (STPs).
Analytes Udupi STP Mangalore STP
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verapamil in influent from STPU in India was six times higher than
in the USA (1.2), which can either result from the microbial trans-
formation in STPU and/or the potential direct discharge of verap-
amil into the wastewater in the USA. The mean concentrations of
antipsychotics such as aripiprazole, diazepam, and oxazepam in
effluent from India were 42, 14, and 11 times, respectively, higher
than in the USA, whereas the mean concentrations of venlafaxine,
diltiazem, and verapamil in effluent from the USAwere 24, 39, and
13 times, respectively, higher than in India. The different profiles of
pharmaceuticals and their metabolites in wastewater from STPs in
India and the USA indicate the different consumption patterns of
drugs as well as the effectiveness of wastewater treatment strate-
gies and/or different extent of dilution. It may be important to note
that the samples were collected in IndianWWTPs prior tomonsoon
season (therefore, dilution can be significantly lower than in
monsoon season). Moreover, the different contamination profiles of
PPCPs in India and in the USA highlight the importance of region-
specific monitoring (Anumol et al., 2016).
3.3. Mass loading of PPCPs into STPs
The mass of PPCPs enters into the STPs via wastewater influent
was calculated as mg/d/1000 inhabitants, using the concentration
of PPCPs in influent, population served, and the volume of waste-
water inflow (Eqn (1)). The total mass load of all PPCPs analyzed in
this study at STPU (4.97 g/d/1000 inhabitants) was 3.6 times higher
than that calculated for STPM (Fig. 1 and Table S3). The sum of the
mass loads of caffeine and its metabolite, paraxanthine, (~4.0 g/d/
1000 inhabitants) were ~4 times higher than the total mass loads of
all other pharmaceuticals in STPU. In both STPs, the mass loading of
caffeine (a stimulant) was followed by analgesics (acetaminophen,
ibuprofen, and mefenamic acid), an antihypertensive (atenolol),
and an antimicrobial (triclocarban) (Fig. 1 and Table S3). Consid-
ering that the sum mass loads of all analytes in a STP as 100%,
percentage loads of each class of PPCPs were calculated. Average
percentage mass loading of the stimulant in STPU and STPM was
75.5% followed by analgesics (12.5%), antimicrobial (5.1%), anti-
hypertensions (3.2%), antipsychotics (1.3%), and antibiotics (1.3%)
(Fig. 2A and B). Moreover, the mass loads of norverapamil
(metabolite of verapamil) and clopidogrel carboxylic acid (metab-
olite of clopidogrel) were 7.2 and 1.6 times higher than their parent
drugs, respectively. Verapamil and norverapamil excrete in the
concentration ratio of 0.47 through human urine (Schwartz et al.,
1985), which suggests that approximately two times higher
concentration of norverapamil than verapamil in wastewater
influent. However, the microbial or chemical ambience in
Table 1 (continued )
Analytes Udupi STP Mangalore STP













































































ND: non-detects; LOQ: limit of quantitation; pharmaceutical metabolites are italicized; bold values are the mean concentrations; values in parenthesis are the detection
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Fig. 1. The average mass loading and environmental emission of select PPCPs from two
STPs in India and two STPs in New York, USA (Subedi and Kannan, 2015). APPZ: ari-
piprazole; DAPPZ: dehydro-aripiprazole; QTP: quetiapine; NQTP: norquetiapine; LZP:
lorazepam; APZ: alprazolam; DZP: diazepam; OxZP: oxazepam; NDZP: nordiazepam;
CBZ: carbamazepine; VLF: venlafaxine; BPP: bupropion, STL: sertraline; NSTL: norse-
traline; PPN: propranolol; ANL: atenolol; DTZ: diltiazem; DAD: desacetyl diltiazem;
VPM: verapamil; NVP: norverapamil; DPH: diphenhydramine; CPG: clopidogrel; CPGC:
clopidogrel carboxylic acid.
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wastewater can enhance degradation/transformation of verapamil
including O-demethylation that can lower verapamil levels in
influents.
Most studies that report mass loadings of PPCPs into the STPs
and/or discharge from STPs based only on the concentrations of
parent drugs measured. However, this study demonstrates that the
estimated mass loadings can be underestimated by two fold by
excluding the concentrations of metabolites in wastewater. Based
on the average per capita usage of water in an Indian urban com-
munity (250 L), water usage by the population in Udupi (38 MLD)
was calculated as ~3 times more than the existing capacity of STPU.
Similarly, water usage by the population in Mangalore (113 MLD) is
~1.5 times more than the existing capacity of STPM. Owing to these
imbalances in the estimated demand and supply, there is a po-
tential growth in water replenishment strategies including water
reuse schemes in Indian communities (Anumol et al., 2016). This
study shows the need for further studies to understand the mass
loads and fates of PPCPs in water.
3.4. Removal of PPCPs
STPU employs a conventional aerobic bio-degradation with
activated sludge while STPM uses UASBR (anaerobic bio-
degradation) as well as secondary aerobic biological treatment
with activated sludge followed by final clarification and chlorine
disinfection. Efficiency (%) of STPU and STPM to remove PPCPs was
calculated using Eqn (2). Average removal efficiency of triclocarban,
miconazole, acetaminophen, diltiazem, verapamil, norverapamil,
oxybenzone, caffeine, and paraxanthine were 82e99% while
trimethoprim, clindamycin, mefenamic acid, quetiapine, loraze-
pam, diphenhydramine, and atenolol were removed at 50%
(Fig. 3). The removal efficiency of psychoactive drugs was found
similar to that from STPs in the USA (Subedi et al., 2015). Recalci-
trant PPCPs such as carbamazepine, diazepam, and clopidogrel
were found to have negative or no removal from STPU while UASBR
treatment (anaerobic bio-degradation) at STPM provided significant
(up to 95%) removal of these PPCPs from STPM. In addition to the
limited treatment, high mass loading in the STPM and low contact
time for biological treatment contribute to a lower PPCP removal
efficiency in comparison with that of STPU. PPCP metabolites such
as desacetyl diltiazem (metabolite of diltiazem) and clopidogrel
carboxylic acid (metabolite of clopidogrel) were found to have
negative removal efficiency. Microbial transformation of parent or
conjugated forms of these drugs during wastewater treatment
process can increase the levels of metabolites in waste streams
(Calisto and Esteves, 2009; Subedi et al., 2015).
3.5. PPCPs emission into the environment
Although select PPCPs were significantly removed during
wastewater treatment processes, significant levels of other PPCPs
were found in effluents and sewage sludge (used as biosolids). The
total mass of PPCPs and their select metabolites (mg/d/1000 in-
habitants) discharged into the environment through effluent
discharge and sludge disposal was calculated based on the con-
centration of PPCPs in effluent, wastewater outflow rate,
Fig. 2. Percentage composition profiles of selected PPCPs in wastewater. A: STPU influent; B: STPM influent; C: STPU effluent; and D: STPM effluent.
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concentration of PPCPs in sewage sludge, total amount of sewage
sludge produced, and the population served by the STP (Eqn (3)).
The total emission/discharge of PPCPs from STPU was signifi-
cantly higher than from STPM (Mann-Whitney Rank Sum Test:
p ¼ 0.003). Caffeine, atenolol, ibuprofen, acetaminophen, mefe-
namic acid, triclocarban, carbamazepine, clopidogrel, and atorvas-
tatin were the major PPCPs discharged from both STPs (Fig. 1 and
Table S3). The total emission of caffeine and its metabolite (stim-
ulant, 91.4 mg/d/1000 inhabitants) from STPU was followed by
atenolol (a hypertensive, 74.9 mg/d/1000 inhabitants), ibuprofen
(an analgesic, 49.0 mg/d/1000 inhabitants, and triclocarban (an
antimicrobial, 34.6 mg/d/1000 inhabitants). The emission of aten-
olol from STPU (serving 150,000 people) was two times lower than
that from a STP in Spain (serving 277,000 people: 149.5 mg/d/1000
inhabitants) (Radjenovic et al., 2009) and 4.7 times lower than that
reported for a STP in the USA (serving ~100,000 people: 355 mg/d/
1000 inhabitants) (Subedi and Kannan, 2015). Similarly, the emis-
sion of carbamazepine from STPU was similar to that from a STP in
Spain (36.8 mg/d/1000 inhabitants) (Radjenovic et al., 2009) but
approximately an order ofmagnitude lower than that of a STP in the
USA (226 mg/d/1000 inhabitants) (Subedi and Kannan, 2015).
Overall, 5.1 kg of caffeine, 4.1 kg of atenolol, 2.7 kg of ibuprofen, and
1.9 kg of triclocarban were discharged annually from STPU that
employed a conventional aerobic biological treatment with acti-
vated sludge and serves an average population of 150,000 in India.
Similarly, 39.5 kg of PPCPs (analytes in this study) were discharged
annually from STPM that employed UASBR and secondary aerobic
biological treatment with activated sludge and serves an average
population of 450,000 in India. Carbamazepine (an antipsychotic),
clopidogrel (antiplatelet and its metabolite clopidogrel carboxylic
acid), and atorvastatin (an antihypercholesterolemic) were dis-
charged at 9e29 mg/d/1000 inhabitants in both STPs.
India currently regulates the chemical discharge frommunicipal
wastewater effluent and sewage sludge through Hazardous Waste
(Management, Handling, and Transboundary Movement) Wastes
Rules (GIMEF, 2008) as the regulations of organic contaminants in
wastewater including PPCPs in the USA (USEPA) and the regulation
of land application of sewage sludge in Europe (CEC, 1986). Insuf-
ficient number of STPs and lack of enforcement of regulations can
result in higher environmental emission of PPCPs than we esti-
mated in this study. This study has provided important information
on the fate of different classes of PPCPs in Indian STPs which can be
useful for regulatory authorities to evaluate the environmental
discharge of PPCPs and implement strategic guidelines to alleviate
ecological risk and to improve environmental sustainability.
4. Conclusions
Twenty-nine pharmaceuticals and six of their metabolites were
determined in two STPs in southern India. The contamination
profiles of selected pharmaceuticals and their metabolites in
wastewater were found different in comparison with that in the
USA, which indicates different consumption patterns of drugs,
effectiveness of wastewater treatment strategies, and/or different
extent of dilution. Average percentage mass loading of the selected
29 PPCPs in STPU and STPM was found in the order of stimulant
(75.5%) > analgesics (12.5%) > antimicrobial (5.1%) > anti-
hypertensions (3.2%) > antipsychotics (1.3%) > antibiotics (1.3%).
Average removal efficiency of most of the PPCPs were50% in both
STPs, while selected PPCPs such as carbamazepine, diazepam, and
clopidogrel were removed significantly (up to 95%) at STPM (which
employs UASBR treatment) but negative or no removal at STPU. It
was found that 5.1 kg of caffeine, 4.1 kg of atenolol, 2.7 g of
ibuprofen, and 1.9 kg of triclocarbanwere discharged annually from
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Fig. 3. Average removal efficiency (% ± StDev) of PPCPs from STPU and STPM. *antimicrobial; **antihistamine (diphenhydramine), antiplatelet (clopidogrel and its metabolite
clopidogrel carboxylic acid), hypercholesteremic (Atorvastin), and UV-filter (oxybenzone); ***stimulant (caffeine and its metabolite paraxanthine).
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